Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
ABBV-399, A c-met antibody-drug conjugate that targets both -amplified and c-Met-overexpressing tumors, irrespective of pathway dependence
If you have any questions regarding this bundle, please call us at 866-855-6468
In published in vitro and preclinical research, BPC-157 has been studied in connection with fibroblast migration, nitric oxide (NO) pathway modulation, and VEGF-related signaling
Omary et al
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, American Heart Association Statistics C and Stroke Statistics S (2011) Heart disease and stroke statistics2011 update: a report from the American Heart Association
US$ 22.15
US$ 26.85
US$ 22.23
US$ 27.51
US$ 19.99